Clinical Trials Browser

Phase NA × Carcinoma, Hepatocellular × Aspirin × Clear all

NCT02748304 2019-02-15

Sorafenib Combined With Aspirin to Prevent the Recurrence in High-risk Patients With Hepatocellular Carcinoma

Phase NA Terminated

Gastrointestinal

Carcinoma, Hepatocellular